dr. J.F.M. (Job) van Boven

A/Prof. dr. Job van Boven is a real-world drug outcomes expert specialised in lung diseases. He is the founding director of the Medication Adherence Expertise Center Of the northern Netherlands (MAECON) and Chair of the European Commission funded European Network to Advance Best Practices & Technology on Medication Adherence (ENABLE) COST Action, comprising 40 countries. He leads the research group on Cost-effective Drug Use (in Dutch: Doelmatig Geneesmiddelgebruik) at the Department of Clinical Pharmacy & Pharmacology of the University Medical Center Groningen and is Principal Investigator at the Groningen Research Institute for Asthma and COPD (GRIAC) and Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET) group of the UMCG.
He obtained his PharmD and PhD at the University of Groningen (The Netherlands), where his thesis focused on the cost-effectiveness of adherence enhancing interventions in patients with Chronic Obstructive Pulmonary Disease (COPD). After his PhD research, he completed fellowships at the University of Colorado (USA), Monash University (Australia) and the Hospital Universitario Son Espases (Spain).
He is (co)author of >200 scientific publications (H-index: 44), supervisor of 10 PhD students and received several research prices & grants (totalling>€6 million). He is Chair of the European Respiratory Society CRC on digital respiratory health "CONNECT", Chair of the Dutch respiratory pharmacists group (KNMP SIG Long), former Boardmember of the Dutch young Medicines Evaluation Board (Jong CBG), ZonMW-GGG committee member, Scientific lead of the Lung Alliance Netherlands (LAN) National Medication Adherence Program, research faculty at the IPCRG & EAACI, Editorial Board member of various peer-reviewed journals and has an extensive international network (e.g. ERS, IPCRG, EAACI, ISPE, REG, ESPACOMP, ISPOR).
Having interest and wide experience in both medication adherence and health economic methods, his mission is to find novel, cost-effective ways to make better, personalized use of our respiratory medications in order to maximize both patients’ and societal benefits.
Through multidisciplinary research, education and care support, he aims to provide means to accelerate implementation of drug-device technologies (digital inhalers, electronic pill bottles & blisters and smart spacers) and practical adherence monitoring & management tools (e.g. the TAI Toolkit) in daily clinical practice to ultimately optimize patient, economic and societal outcomes.

Specialties:
- Methods & application: medication adherence, compliance, persistence, e-health, smart inhalers, bottles and spacers, digital adherence technology, (pharmaco) epidemiology, real-world drug outcomes, health economics, health technology assessment, cost-effectiveness.
- Disease focus areas: Asthma / COPD / TB / CF / Lung cancer  

Founding director Therapietrouw Expertise Center (MAECON)
Chair European Network to Advance Best practices & technoLogy on medication adherencE (ENABLE) COST Action
Voorzitter KNMP Special Interest Group Longziekten
Commissie lid ZonMW Goed Geneesmiddel Gebruik (GGG)
Voormalig Collegelid jong College ter Beoordeling van Geneesmiddelen (CBG)
Lid wetenschappelijke redactie van de tijdschriften "npj Primary Care Respiratory Medicine", "Frontiers in Medical Technology", "Clinical eHealth", "Tuberculosis & Respiratory Diseases" en "Pragmatic & Observational Research"
European Academy of Allergy & Clinical Immunology (EAACI) ROC Advisory Committee Member
International Primary Care Respiratory Group (IPCRG) Research Leadership Team (Member)
Respiratory Effectiveness Group (REG) Adherence working group (Member)
Ad-hoc consultant to various companies (AstraZeneca, Chiesi, GSK, Novartis, TEVA, Vertex)
Wetenschappelijk projectleider Nationaal LAN zorgpad Inhalatiemedicatie en therapietrouw
Technical Board member, Makerere University Lung Institute, Uganda
Co-Chair European Respiratory Society (ERS) Clinical Research Collaboration (CRC) "CONNECT" on digital respiratory health
Bestuurslid Long Alliantie Nederland (LAN)
Wetenschappelijke Advies Commissie lid Longfonds